KREBSBIO.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:59):

Stats
Tagesvolumen	3 926.00
Durchschnittsvolumen	14 858.00
Marktkapitalisierung	1.57B
EPS	INR0 ( 2024-02-11 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-21
Last Dividend	INR2.90 ( 2005-09-14 )
Next Dividend	INR0 ( N/A )
P/E	-7.68
ATR14	INR0.383 (0.52%)

Krebs Biochemicals & Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Krebs Biochemicals & Finanzdaten

Annual	2022
Umsatz:	INR521.34M
Bruttogewinn:	INR264.57M (50.75 %)
EPS:	INR-11.45

FY	2022
Umsatz:	INR521.34M
Bruttogewinn:	INR264.57M (50.75 %)
EPS:	INR-11.45

FY	2022
Umsatz:	INR529.41M
Bruttogewinn:	INR-207.59M (-39.21 %)
EPS:	INR-20.74

FY	2021
Umsatz:	INR386.06M
Bruttogewinn:	INR-136.26M (-35.29 %)
EPS:	INR-14.53

Financial Reports:

No articles found.

Krebs Biochemicals & Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Krebs Biochemicals & Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 3.18 - No dividend growth expected in the near future

Information

First Dividend	INR2.90	2005-09-14
Last Dividend	INR2.90	2005-09-14
Next Dividend	INR0	N/A
Payout Date	2005-10-01
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR2.90	--
Avg. Dividend % Per Year	0.00%	--
Score	0.38	--
Div. Sustainability Score	0
Div.Growth Potential Score	3.18
Div. Directional Score	1.228	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.38

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TIDEWATER.NS	Dividend Knight	2023-07-04	Semi-Annually	18	2.24%
PAISALO.NS	Dividend Junior	2023-09-14	Annually	16	0.10%
ITDC.NS	Dividend Junior	2023-09-20	Sporadic	8	0.17%
DAAWAT.NS	Dividend Junior	2023-09-21	Annually	18	1.02%
SHREYANIND.NS	Dividend Junior	2023-08-03	Annually	12	1.43%
MASFIN.NS	Dividend Junior	2023-07-19	Annually	8	0.28%
GRPLTD.NS	Dividend Junior	2023-07-28	Annually	10	0.46%
BANARISUG.NS	Dividend Junior	2023-08-28	Annually	22	0.34%
POWERINDIA.NS	Dividend Junior	2023-08-10	Annually	4	0.07%
JUBLINGREA.NS	Dividend Junior	2023-08-10	Semi-Annually	4	0.47%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.417	1.500	-8.34	-10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.200	1.500	8.88	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-3.69	1.000	-2.48	-2.48	[3 - 30]
operatingCashFlowPerShareTTM	6.10	2.00	7.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.10	2.00	6.95	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.739	1.000	1.015	1.015	[0.2 - 0.8]
operatingProfitMarginTTM	-0.329	1.000	-8.57	-8.57	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.725

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7.56	1.000	-0.865	0	[1 - 100]
returnOnEquityTTM	0.200	2.50	9.28	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.10	2.00	7.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.10	2.00	7.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.176	1.500	-2.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.263	1.000	5.91	0	[0.1 - 0.5]
Total Score				3.18

Krebs Biochemicals &

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.